NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 19 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,457,918 | -0.4% | 1,574,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,463,820 | -37.3% | 1,574,000 | -38.9% | 0.00% | – |
| Q4 2022 | $2,335,905 | -54.8% | 2,574,000 | -53.8% | 0.00% | -100.0% |
| Q3 2022 | $5,166,000 | +0.9% | 5,574,000 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $5,118,000 | -12.8% | 5,568,000 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $5,869,000 | -5.4% | 5,557,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,206,000 | -30.2% | 5,557,000 | -16.0% | 0.00% | 0.0% |
| Q3 2021 | $8,891,000 | -11.7% | 6,613,000 | +13.8% | 0.00% | 0.0% |
| Q2 2021 | $10,064,000 | +52.4% | 5,811,000 | +33.5% | 0.00% | 0.0% |
| Q1 2021 | $6,605,000 | -9.1% | 4,353,000 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $7,266,000 | +52.5% | 4,000,000 | +30.3% | 0.00% | 0.0% |
| Q3 2020 | $4,765,000 | -37.5% | 3,069,000 | -44.8% | 0.00% | -50.0% |
| Q2 2020 | $7,624,000 | – | 5,556,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 61,000,000 | $65,368,000 | 1.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 50,366,000 | $53,863,000 | 0.53% |
| DeepCurrents Investment Group LLC | 12,930,000 | $13,857,000 | 0.43% |
| Aequim Alternative Investments LP | 7,300,000 | $7,891,000 | 0.21% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,290,000 | $5,656,000 | 0.09% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,167,000 | $32,611,000 | 0.09% |
| Verition Fund Management LLC | 3,823,000 | $4,133,000 | 0.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,534,000 | $1,643,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,000,000 | $12,972,000 | 0.02% |
| Rock Springs Capital Management LP | 500,000 | $541,000 | 0.01% |